Macrophage Migration Inhibitory Factor Is a Molecular Determinant of the Anti-EGFR Monoclonal Antibody Cetuximab Resistance in Human Colorectal Cancer Cells

Macrophage Migration Inhibitory Factor Is a Molecular Determinant of the Anti-EGFR Monoclonal Antibody Cetuximab Resistance in Human Colorectal Cancer Cells

Background: The clinical impact of the monoclonal antibody cetuximab targeting the EGFR in colorectal cancer (CRC) is widely recognized. Nevertheless, the onset of cetuximab resistance is a serious issue that limits the effectiveness of this drug in targeted therapies. Unraveling the molecular playe...

Full description

Bibliographic Details
Main Authors: Rosita Russo, Nunzia Matrone, Valentina Belli, Davide Ciardiello, Mariangela Valletta, Sabrina Esposito, Paolo Vincenzo Pedone, Fortunato Ciardiello, Teresa Troiani, Angela Chambery
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Cancers
Subjects:
cetuximab
colorectal cancer
drug resistance
mif
mass spectrometry (ms)
Online Access:https://www.mdpi.com/2072-6694/11/10/1430

Internet

https://www.mdpi.com/2072-6694/11/10/1430

Similar Items